|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
1603582177 |
003 |
DE-627 |
005 |
20230905071142.0 |
007 |
tu |
008 |
990525s1999 sz ||||| 00| ||eng c |
010 |
|
|
|a 99010441
|
020 |
|
|
|a 3764357800
|c (soft cover : alk. paper)
|9 3-7643-5780-0
|
020 |
|
|
|a 0817657800
|c (soft cover : alk. paper)
|9 0-8176-5780-0
|
035 |
|
|
|a (DE-627)1603582177
|
035 |
|
|
|a (DE-576)077665589
|
035 |
|
|
|a (DE-599)BSZ077665589
|
035 |
|
|
|a (OCoLC)246030853
|
035 |
|
|
|a (OCoLC)40674941
|
035 |
|
|
|a (AT-OBV)AC02594323
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
044 |
|
|
|c XA-CH
|c XD-US
|c XA-DE
|
050 |
|
0 |
|a RM370.P75 1999
|
050 |
|
0 |
|a RM370
|
060 |
|
0 |
|a QW 540
|
082 |
0 |
|
|a 616.07/9
|
082 |
0 |
4 |
|a 33
|
084 |
|
|
|a XI 6600
|2 rvk
|0 (DE-625)rvk/153022:12905
|
084 |
|
|
|a 44.38
|2 bkl
|
084 |
|
|
|a 44.45
|2 bkl
|
245 |
1 |
0 |
|a Principles of immunopharmacology
|c ed. by F. P. Nijkamp ...
|
264 |
|
1 |
|a Basel [u.a.]
|b Birkhäuser Verlag
|c 1999
|
300 |
|
|
|a XVI, 496 S.
|b graph. Darst.
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Literaturverzeichnis Seite 443-486
|
583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 3
|2 pdager
|
650 |
|
0 |
|a Immunopharmacology
|
650 |
|
0 |
|a Immunotoxicology
|
650 |
|
0 |
|a Immunodiagnosis
|
650 |
|
0 |
|a Immune system
|x Effect of drugs on
|
650 |
|
0 |
|a Immunity
|x drug effects
|
650 |
|
0 |
|a Immunity, Cellular
|x physiology
|
650 |
|
0 |
|a Adjuvants, Immunologic
|x pharmacology
|
650 |
|
0 |
|a Immunosuppressive Agents
|x pharmacology
|
650 |
|
0 |
|a Immunotherapy
|
650 |
|
0 |
|a Immunologic Tests
|
650 |
|
2 |
|a Immunity
|x drug effects
|
650 |
|
2 |
|a Immunity, Cellular
|x physiology
|
650 |
|
2 |
|a Adjuvants, Immunologic
|x pharmacology
|
650 |
|
2 |
|a Immunosuppressive Agents
|x pharmacology
|
650 |
|
2 |
|a Immunotherapy Immunologic Tests
|
653 |
|
0 |
|a Immunopharmacology
|
653 |
|
0 |
|a Immunotoxicology
|
653 |
|
0 |
|a Immunodiagnosis
|
653 |
|
0 |
|a Immune system
|a Effect of drugs on
|
653 |
|
0 |
|a Immunity
|a drug effects
|
653 |
|
0 |
|a Immunity, Cellular
|a physiology
|
653 |
|
0 |
|a Adjuvants, Immunologic
|a pharmacology
|
653 |
|
0 |
|a Immunosuppressive Agents
|a pharmacology
|
653 |
|
0 |
|a Immunotherapy
|
653 |
|
0 |
|a Immunologic Tests
|
655 |
|
7 |
|a Aufsatzsammlung
|0 (DE-588)4143413-4
|0 (DE-627)105605727
|0 (DE-576)209726091
|2 gnd-content
|
689 |
0 |
0 |
|D s
|0 (DE-588)4026639-4
|0 (DE-627)106287486
|0 (DE-576)208967370
|a Immunpharmakologie
|2 gnd
|
689 |
0 |
|
|5 DE-101
|
689 |
1 |
0 |
|D s
|0 (DE-588)4026639-4
|0 (DE-627)106287486
|0 (DE-576)208967370
|a Immunpharmakologie
|2 gnd
|
689 |
1 |
|
|5 (DE-627)
|
689 |
2 |
0 |
|D s
|0 (DE-588)4026639-4
|0 (DE-627)106287486
|0 (DE-576)208967370
|a Immunpharmakologie
|2 gnd
|
689 |
2 |
|
|5 (DE-627)
|
700 |
1 |
|
|a Nijkamp, Frans P.
|e hrsg
|0 (DE-627)1237348439
|0 (DE-576)167348434
|4 edt
|
700 |
1 |
|
|a Nijkamp, Franciscus P.
|d 1947-
|0 (DE-588)132192780
|0 (DE-627)690414706
|0 (DE-576)29899710X
|4 oth
|
700 |
1 |
|
|a Parnham, Michael J.
|d 1951-
|0 (DE-588)172301874
|0 (DE-627)697210642
|0 (DE-576)133168832
|4 oth
|
856 |
4 |
2 |
|u https://swbplus.bsz-bw.de/bsz077665589cov.jpg
|m V:DE-576
|q text/html
|3 Cover
|
856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/254573959.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/254573959.pdf
|x Verlag
|z kostenfrei
|3 Inhaltsverzeichnis
|
889 |
|
|
|w (DE-627)254573959
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a ISIL_DE-1a
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a SSG-OPC-DE-84
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a ISIL_DE-84
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a ISIL_DE-18
|
912 |
|
|
|a GBV_ILN_22_i06404
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a ISIL_DE-27
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a ISIL_DE-28
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a ISIL_DE-3
|
912 |
|
|
|a GBV_ILN_65_a024
|
912 |
|
|
|a GBV_ILN_65_a065
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a ISIL_DE-9
|
912 |
|
|
|a GBV_ILN_74
|
912 |
|
|
|a ISIL_DE-354
|
912 |
|
|
|a GBV_ILN_101
|
912 |
|
|
|a ISIL_DE-Ma14
|
912 |
|
|
|a GBV_ILN_2007
|
912 |
|
|
|a ISIL_DE-352
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a ISIL_DE-24
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a ISIL_DE-15-292
|
912 |
|
|
|a GBV_ILN_2011
|
912 |
|
|
|a ISIL_DE-16
|
935 |
|
|
|i mdedup
|
936 |
r |
v |
|a XI 6600
|b Allgemeines
|k Medizin
|k Pharmakologie und Toxikologie
|k Spezielle Pharmakologie und Toxikologie
|k Immunsuppressiva
|k Allgemeines
|0 (DE-627)1271551748
|0 (DE-625)rvk/153022:12905
|0 (DE-576)201551748
|
936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
936 |
b |
k |
|a 44.45
|j Immunologie
|0 (DE-627)106409689
|
951 |
|
|
|a BO
|
953 |
|
|
|2 045F
|a 616.07/9
|
980 |
|
|
|2 11
|1 01
|x 0001
|b 422069272
|c 00
|f 2
|d 1 B 71283
|e u
|j --%%--
|y k
|z 09-01-01
|
980 |
|
|
|2 20
|1 01
|x 0084
|b 308145917
|c 00
|f --%%--
|d 2779-6368
|e --%%--
|j --%%--
|y k
|z 12-08-99
|
980 |
|
|
|2 22
|1 01
|x 0018
|b 360857221
|c 00
|f 18/64
|d QW 540 Med B 1999/103
|e u
|j --%%--
|c 03
|f --%%--
|d Med B 1999/103
|e --%%--
|j --%%--
|y zi06404
|z 18-10-99
|
980 |
|
|
|2 31
|1 01
|x 0027
|b 94395634X
|c 00
|f J 43
|d MED:PP:2000:Nij::1999
|e d
|j --%%--
|y r
|z 11-08-09
|
980 |
|
|
|2 62
|1 01
|x 0028
|b 352056215
|c 00
|f 28/BB4
|d XI 6600 N691
|e u
|j --%%--
|c 09
|f --%%--
|d 99 A 27070
|e --%%--
|j --%%--
|y zbb4
|z 17-08-99
|
980 |
|
|
|2 65
|1 01
|x 3/150
|b 354382276
|c 00
|f Ha 150
|d XI 6600 101
|e u
|j --%%--
|c 09
|f Ha 150
|d LS 44.38/2000:0438b
|e --%%--
|j --%%--
|y ra024
|z 09-09-99
|
980 |
|
|
|2 65
|1 02
|x 3/150
|b 402300173
|c 00
|f Ha 150-M
|d 2000:0438
|e u
|j --%%--
|c 09
|f --%%--
|d I 214 / 44.38/2000:0438
|e --%%--
|j --%%--
|y ra065
|z 04-09-00
|
980 |
|
|
|2 69
|1 01
|x 0009
|b 362488029
|c 00
|f UB 660
|d 660/XI 6600 N691
|e u
|j --%%--
|y z
|z 29-10-99
|
980 |
|
|
|2 74
|1 01
|x 0354
|b 4478808953
|c 00
|f MedGesch
|d QW 504"ME 7452
|e u
|j --%%--
|y zm
|z 07-02-24
|
980 |
|
|
|2 101
|1 01
|x 3101
|b 347382983
|c 00
|f 0311.03
|d ZB -0311-468
|e u
|j --%%--
|y l
|z 10-09-99
|
980 |
|
|
|2 101
|1 02
|x 3101
|b 36946706X
|c 00
|f IKP
|d KPha-0311-011
|e --%%--
|j --%%--
|y z
|z 07-12-99
|
980 |
|
|
|2 2007
|1 01
|x DE-352
|b 3095413653
|c 00
|f --%%--
|d bio 988.30:n/n44
|e --%%--
|j --%%--
|y l01
|z 25-05-99
|
980 |
|
|
|2 2008
|1 01
|x DE-24
|b 3095413742
|c 00
|f --%%--
|d 49a/1210
|e --%%--
|j --%%--
|k st 3a
|y l01
|z 04-02-00
|
980 |
|
|
|2 2010
|1 01
|x DE-15-292
|b 3095413823
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 23-08-00
|
980 |
|
|
|2 2011
|1 01
|x DE-16
|b 3095413866
|c 00
|f --%%--
|d UBN/XI 6600 N691
|e --%%--
|j --%%--
|y l01
|z 16-10-00
|
982 |
|
|
|2 62
|1 00
|x DE-28
|8 00
|s s
|a Immunopharmakologie
|
982 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a Immunity-drug effects
|
982 |
|
|
|2 74
|1 00
|x DE-354
|8 01
|a Adjuvants, Immunologic-pharmacology
|
982 |
|
|
|2 74
|1 00
|x DE-354
|8 02
|a Immunosuppressive Agents-pharmacology
|
982 |
|
|
|2 74
|1 00
|x DE-354
|8 03
|a Immunologic Tests
|
982 |
|
|
|2 74
|1 00
|x DE-354
|8 04
|a Immunotherapy
|
983 |
|
|
|2 69
|1 00
|x DE-9
|8 00
|a XI 6600
|
983 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a QW 504
|
983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 00
|a 0311.03
|
983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 01
|a 0602.07
|
984 |
|
|
|2 11
|1 01
|x 0001
|a 132360018010
|
984 |
|
|
|2 20
|1 01
|x 0084
|a 84$027796368
|
984 |
|
|
|2 22
|1 01
|x 0018
|a 056471258
|
984 |
|
|
|2 31
|1 01
|x 0027
|a 27$024341428
|
984 |
|
|
|2 62
|1 01
|x 0028
|a 28$001809075
|
984 |
|
|
|2 65
|1 01
|x 3/150
|a 3/6$000035742
|
984 |
|
|
|2 65
|1 02
|x 3/150
|a 3/150$00074292
|
984 |
|
|
|2 69
|1 01
|x 0009
|a 9$01991213
|x 00
|
984 |
|
|
|2 74
|1 01
|x 0354
|a 354$13363255
|
984 |
|
|
|2 101
|1 01
|x 3101
|a MA14$0702404
|
985 |
|
|
|2 22
|1 01
|x 0018
|a uke1999.2218
|
985 |
|
|
|2 62
|1 01
|x 0028
|a 99 A 27070
|
985 |
|
|
|2 62
|1 01
|x 0028
|a 28/039
|
985 |
|
|
|2 65
|1 01
|x 3/150
|a 24/1999/00018
|
985 |
|
|
|2 65
|1 02
|x 3/150
|a 65/2000/00038
|
985 |
|
|
|2 69
|1 01
|x 0009
|a 99.13317
|
985 |
|
|
|2 74
|1 01
|x 0354
|a ME 7452
|